Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu) TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21 Exposure to ionizing radiation has been proven to cause cancer and initiate mutagenesis in human and animal cells.
1,2 Studies of radiation-induced mouse thymic lymphomas, one of the classic models in radiation carcinogenesis, demonstrated that many factors like oncogene Ras and tumor suppressor gene p53 were involved in radiation-induced carcinogenesis. 1 Our previous studies also found that ERK1/2, STAT3 and SHP-2 are also involved in g-ray-induced thymic lymphomas in BALB/c mice. 3 However, the mechanisms by which radiation induces thymic lymphomas are still unclear.
Toll-like receptor (TLR)-4 belongs to the recently identified TLRs, which are the main sentinels in many types of immune cells. 4, 5 Recent studies have shown that TLR4 functions not only as a sensor of microbial infection, where it is critical for the initiation of inflammatory and immune defense responses, but also Letters to the Editor has a direct relationship with the pathogenesis of many human and mouse diseases, such as infectious disease, autoimmune disease, diabetes mellitus and others. 4, 5 However, the role of TLR4 in radiation-induced leukemia is not well known.
To examine a potential role of the TLR4 in radiation-induced thymic lymphomas, we subjected sex (equal number of male and female) and age-matched (5 weeks in age) TLR4 þ / þ mice (C57BL/10 wild type, 18 g), TLR4
À/À mice (C57BL/10ScNJ TLR4 gene deleted type, 18 g) and TLR4
þ /À mice (F1 of C57BL/ 10 Â C57BL/10ScNJ, 18 g) to four weekly 1.75 Gy g-ray exposures at a dose rate of 0.58 Gy/min as described previously. 3 On average, 70% of TLR4 þ /À and TLR4 þ / þ mice died within 12-35 weeks after the last irradiation (from all causes), but the most important cause of death was thymic lymphomas, whereas the non-irradiated control mice all lived to 35 weeks. 1, 3 In contrast, the mortality of TLR4 À/À mice were dramatically reduced as compared with TLR4
þ /À and TLR4 þ / þ mice, which had no significant difference. As TLR4 þ /À and TLR4 þ / þ mice didn't show a significant difference, we subsequently compared TLR4 À/À mice and TLR4 þ /À mice ( Figure 1a ). We investigated body weight loss, a marker of thymic lymphomagenesis, 20 weeks after the last exposure and found that the body weight loss observed in the exposed TLR4 þ /À mice was significantly reduced, compared with exposed agematched TLR4
À/À mice 20 weeks after last irradiation ( Figure 1b) . Thus, the data further indicate that TLR4 signaling may contribute to the severe mortality and lymphomagenesis caused by split-dose irradiation.
The thymic tumor incidence rate and the sizes of each thymus or thymic lymphoma were quantified by microscopy and histological studies. The tumor incidence rate in exposed TLR4 À/À mice was reduced compared with age-matched exposed TLR4
þ /À mice ( Figure 1c ). Thymic lymphomas present in exposed TLR4
À/À mice were also smaller in size. In particular, the fraction of macro-lymphomas (X10.0 mm in diameter) in TLR4 À/À mice were reduced compared with those in TLR4 þ /À mice ( Figure 1c ). These finding suggest that the TLR4 signaling pathway regulates split-radiation-induced thymic lymphomagenesis. However, histological analysis found no difference between the thymic lymphomas derived from TLR4 À/À mice or TLR4 þ /À mice (data not shown). As the size of tumors can be influenced by the balance of cell proliferation and death within the tumor mass, we investigated the proliferative and apoptotic rates within size-matched tumors (4.5-5.5 mm in diameter) from exposed TLR4 À/À and TLR4 þ /À mice. Thymic lymphomas from both genotypes showed similar rates of proliferating cells as detected by 5-bromodeoxyuridine assay (Figure 1d ). However, higher numbers of apoptotic cells were found in tumors from TLR4 À/À mice than in tumors from TLR4 þ /À mice as detected by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling assay (Figure 1d ). The apoptosis rate of single-cell suspension detected using flowcytometry method was also consistent with the terminal deoxynucleotidyl transferasemediated deoxyuridine triphosphate nick end labeling assay (data not shown). Thus, TLR4 may contribute to radiationinduced carcinogenesis through downregulation of apoptosis.
Many TLR4-related genes have also been shown to have a critical role in tumor biology and anti-tumor immunity. 4, 5 We further investigated the role of TLR4 in radiation carcinogenesis by comparing gene expression in size-matched radiationinduced lymphomas from TLR4 À/À mice and TLR4 þ /À mice. As can be seen in Figure 2a , the cytokines interleukin (IL) 6, MMP9 (matrix metalloproteinase-9) and COX2 (cyclooxygenases 2) expression were enhanced in the radiation-induced thymic lymphoma tissues when compared with non-irradiated normal thymus tissues. However, the cytokine levels in radiation-induced lymphomas from TLR4 À/À mice were reduced, compared with the expression in size-matched lymphomas from TLR4 þ /À mice. There was no significant difference in the mRNA levels of TNF-a, STAT3, MMP7 and nuclear factor-kB p65 in the lymphomas from different genotypes (data not shown). We also found that miR-21, miR-155 and miR-17-92 family expression were all enhanced in the radiation-induced thymic lymphoma tissues when compared with non-irradiated normal thymus tissues, but the miR-21 and miR-155 levels in radiation-induced lymphomas from TLR4 À/À mice were reduced compared with radiation-induced sizematched lymphomas from TLR4 þ /À mice. There was no significant difference in the miR-17 and miR-92 from these two mice strains (Figure 2a) . The levels of IL6 and miR-21 showed the greatest difference among these factors, indicating they may have a critical role in TLR4-related radiation-induced thymic lymphoma. This data is consistent with previous reports that IL6 level is enhanced in many clinical patients with multiple myeloma, renal cell carcinoma and B-lymphoproliferative disorders. 6 Anti-IL-6 monoclonal antibody therapy has proven to be useful in the treatment of cancer patients by decreasing the incidence of cancer-related anorexia and cachexia. 6 This data is also consistent with previous reports showing that miR-21 is an important oncomiR in many types of tumors. 7 These data, taken together, indicate that TLR4 may contribute to radiation-induced thymic lymphoma by upregulation of IL-6 and miR-21.
We further explored the potential upstream factors of TLR4 that participate in ionizing radiation-induced thymic lymphoma. The most prominent danger signal high-mobility group box 1 protein (HMGB1) is also an important ligand of TLR4. 4, 8 It has been shown to be released from necrotic cells and can activate TLR4 to induce cytokines like IL6, MMP9 and COX2. 8 We found that HMGB1 could be rapidly induced by irradiation, and the expression level of HMGB1 was also enhanced in radiationinduced thymic lymphoma tissues from both TLR4 À/À and TLR4 þ /À mice (Figures 2a and b) . Serum HMGB1 level was enhanced after irradiation and upregulated in thymic lymphoma Letters to the Editor tumor-bearing mice, when compared with normal control nonirradiated mice (Figures 2c and d) . Furthermore, exogenous rmHMGB1 (recombinant mouse HMGB1) showed its capacity to upregulate the IL6 and miR-21 expression level in a TLR4-dependent manner (Figure 2e ). These data indicate the possible important role of HMGB1/TLR4/IL6-miR-21 pathway in radiation-induced carcinogenesis.
Our data presented here may provide a novel possible mechanism for split-dose radiation-induced thymic lymphomas. As shown in Figure 2f , split-dose irradiation may injure the thymus cells, inducing apoptosis and necrosis, and releasing many danger-and death-related signals like HMGB1. This in turn may activate TLR4 and elevate the pro-tumor cytokines IL6 and miR-21, together with important factors like MMP9 and miR-155, to induce carcinogenesis. To the best of our knowledge, this is the first report describing a role for TLR4 in radiation-induced thymic lymphoma in vivo. This work therefore provides some novel experimental evidence about potential therapeutic targets for the prevention and treatment of radiationinduced carcinogenesis.
The t(15;17) translocation that results in the PML/RARA fusion is the disease-defining lesion in nearly all cases of acute promyelocytic leukemia (APL). 1 Despite the importance of the PML/RARA fusion for the pathogenesis of APL, it is most likely not sufficient to cause leukemia. The long latency, incomplete penetrance and additional cytogenetic changes accompanying the onset and progression of the disease in the murine APL models strongly suggest that additional mutations are required for the development of APL. 2 In newly diagnosed patients with APL, approximately 40% have leukemic cells with secondary abnormalities. 3 Collaborating mutations affecting the FLT3 
